RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
This Quarter Return
-6.58%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$3.73B
AUM Growth
+$3.73B
(-11%)
Cap. Flow
-$74.6M
Cap. Flow
% of AUM
-2%
Top 10 Holdings %
Top 10 Hldgs %
36%
Holding
129
New
6
Increased
41
Reduced
24
Closed
9
Top Buys
| 1 |
Boston Scientific
BSX
|
$47.1M |
| 2 |
Penumbra
PEN
|
$33.3M |
| 3 |
BPMC
Blueprint Medicines
BPMC
|
$25M |
| 4 |
Immunovant
IMVT
|
$24.7M |
| 5 |
Amgen
AMGN
|
$18.3M |
Top Sells
| 1 |
argenx
ARGX
|
$44.7M |
| 2 |
Spyre Therapeutics
SYRE
|
$40.1M |
| 3 |
Insulet
PODD
|
$28.5M |
| 4 |
CONMED
CNMD
|
$27.9M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$27.7M |
Sector Composition
| 1 | Healthcare | 97.08% |
| 2 | Consumer Staples | 1.17% |
| 3 | Industrials | 0.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Alnylam Pharmaceuticals
ALNY
$58.5B
| $49.5M | 1.33% | 279,500 -65,500 | -19% | -$11.6M |
|
|
MRTX
27
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $49.3M | 1.32% | 1,131,207 +9,560 | +0.9% | +$416K |
|
28
Sarepta Therapeutics
SRPT
$1.78B
| $47.5M | 1.27% | 392,000 -33,000 | -8% | -$4M |
|
29
Edwards Lifesciences
EW
$47.8B
| $44.8M | 1.2% | 647,300 +1,400 | +0.2% | +$97K |
|
30
Freshpet
FRPT
$2.72B
| $43.6M | 1.17% | 662,500 | – | – |
|
31
Xenon Pharmaceuticals
XENE
$2.98B
| $40.2M | 1.08% | 1,178,002 | – | – |
|
32
Ascendis Pharma
ASND
$11.8B
| $39.8M | 1.07% | 425,500 | – | – |
|
33
Rhythm Pharmaceuticals
RYTM
$6.85B
| $36.6M | 0.98% | 1,597,123 | – | – |
|
34
Phreesia
PHR
$1.88B
| $33.2M | 0.89% | 1,776,391 +471,391 | +36% | +$8.81M |
|
35
iRhythm Technologies
IRTC
$5.46B
| $33.1M | 0.89% | 350,750 +41,300 | +13% | +$3.89M |
|
36
Pacira BioSciences
PCRX
$1.2B
| $32.4M | 0.87% | 1,055,500 +20,500 | +2% | +$629K |
|
|
ACCD
37
DELISTED
Accolade, Inc. Common Stock
ACCD
| $30.8M | 0.83% | 2,913,000 +93,000 | +3% | +$984K |
|
38
Legend Biotech
LEGN
$6.41B
| $30.8M | 0.82% | 458,265 | – | – |
|
39
Zai Lab
ZLAB
$3.68B
| $30.1M | 0.81% | 1,237,023 +14,600 | +1% | +$355K |
|
40
Prothena Corp
PRTA
$441M
| $29.6M | 0.79% | 614,298 -139,164 | -18% | -$6.71M |
|
|
HZNP
41
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $29.6M | 0.79% | 255,500 -239,500 | -48% | -$27.7M |
|
|
SWAV
42
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $29.4M | 0.79% | 147,500 +32,400 | +28% | +$6.45M |
|
|
ABCM
43
DELISTED
Abcam plc American Depositary Shares
ABCM
| $28.9M | 0.77% | 1,275,000 -1,130,000 | -47% | -$25.6M |
|
44
Madrigal Pharmaceuticals
MDGL
$9.76B
| $28.7M | 0.77% | 196,369 -2,849 | -1% | -$416K |
|
45
Amylyx Pharmaceuticals
AMLX
$836M
| $28.3M | 0.76% | 1,545,016 +400 | +0% | +$7.32K |
|
46
Aclaris Therapeutics
ACRS
$209M
| $27.1M | 0.73% | 3,960,449 -1,400 | -0% | -$9.59K |
|
47
Dynavax Technologies
DVAX
$1.19B
| $26.8M | 0.72% | 1,813,758 | – | – |
|
48
Health Care Select Sector SPDR Fund
XLV
$33.9B
| $25.7M | 0.69% | 200,000 | – | – |
|
49
Lifestance Health
LFST
$2.13B
| $25.2M | 0.68% | 3,670,000 +770,000 | +27% | +$5.29M |
|
|
50
Immunovant
IMVT
$2.56B
| $24.7M | 0.66% | +644,344 | New | +$24.7M |
|